Weight-loss drugs are typically not covered by private insurance plans, and in late November, President Joe Biden proposed expanding coverage for these medications for Americans insured by Medicare ...
A new crop of evidence — both anecdotal and research based — is pointing to these drugs as a potential option for people ...
Last week, the Biden administration passed a rule allowing for the government healthcare programs Medicare and Medicaid ...
President Joe Biden's proposal to expand coverage of anti-obesity drugs like Ozempic has divided Republicans. The next ...
Novo Nordisk is a bargain stock with tremendous growth potential. Vertex Pharmaceuticals has seven clear paths to growth ...
Obesity can be deadly for people living with it, but we have potential treatments that can lead to weight loss and ...
Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...
MONTGOMERY — A joint task force charged with researching and proposing solutions for Alabama’s high obesity and diabetes ...
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 525.52% and ...
The holidays are a time known for feasting on delicious food, but that might not be possible for people taking weight-loss drugs.
The expansion of a newly acquired facility in Wisconsin is Lilly’s largest U.S. manufacturing investment outside of Indiana ...